Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Wesley D. McMillian"'
Publikováno v:
Journal of Pharmacy Practice. 34:567-572
Background: Heart failure (HF) is a prevalent and costly disease state for adult Americans, with 30-day readmissions rates for patients with HF utilized to limit hospital compensation. Objective: To determine the impact of the transitions of care (TO
Autor:
Wesley D. McMillian, Joshua D. Farkas, Matthew P. Gilbert, Jeffrey Endicott, Ryan Clouser, Stephen Rappaport
Publikováno v:
Journal of the Endocrine Society
Background Insulin via continuous intravenous infusion (ICII) is a standard of care for treating patients with diabetic ketoacidosis (DKA). Once DKA is resolved, ICII is transitioned to subcutaneous therapy. However, recent guidelines recommend conti
Publikováno v:
American Journal of Health-System Pharmacy. 72:61-63
Purpose A pharmacist’s role in helping Vermont health officials standardize pharmacotherapy-related protocols used by emergency medical services (EMS) personnel across the state is described. Summary Pharmacists with expertise in emergency medicine
Autor:
Wesley D. McMillian, Suzanne Elizabeth Ames, Wallace Kemper Alston, Marian L. Gaviola, Jeffrey Endicott
Publikováno v:
Pharmacotherapy. 36(1)
Background Topical vancomycin may be an effective intervention to decrease the risk of postoperative surgical site infections (SSIs). The primary objective of this study was to evaluate the impact of topical vancomycin with intravenous (IV) cefazolin
Publikováno v:
American Journal of Health-System Pharmacy. 68:130-134
Purpose Use of continuous phentolamine infusion therapy for management of serious cardiovascular complications during adrenalectomy for pheochromocytoma is reported. Summary In preparation for surgical resection of a pheochromocytoma, a 38-year-old w
Publikováno v:
American Journal of Health-System Pharmacy. 66:2076-2083
The use of methadone has come into the spotlight over the past several years, primarily due to its potential benefits over more commonly used oral opioids. These benefits, including lower cost, no known active metabolites, and minimal cross-tolerance
Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa
Autor:
Bruce A. Warden, Jon Case, Gregory Roberti, Darrel W. Hughes, Nathan B. Johnson, Cassie A. Barton, Martin A. Schreiber, Jason Zimmerman, Wesley D. McMillian
Publikováno v:
The American journal of emergency medicine. 33(11)
Bleeding events and life-threatening hemorrhage are the most feared complications of warfarin therapy. Prompt anticoagulant reversal aimed at replacement of vitamin K–dependent clotting factors is essential to promote hemostasis. A retrospective co
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 68(9)
Purpose Current trends and recent developments in use of adaptive trial design methodology for pharmaceutical research, as well as barriers to wider acceptance and implications for pharmacists, are discussed. Summary Traditional clinical drug trials
Autor:
Cassie A. Barton, Wesley D. McMillian, Turner Osler, William E. Charash, Peter A. Igneri, Nicholas C. Brenny, Joseph J. Aloi, John B. Fortune
Publikováno v:
Journal of Trauma and Acute Care Surgery. 72:1124-1125
Publikováno v:
Respiratory Medicine. (6):932-934
SummaryCommunity-acquired methicillin-resistant Staphylococcus aureus is increasingly recognized as an important pathogen causing skin and soft tissue infections. We report a case of severe necrotizing pneumonia caused by community-acquired methicill